Collectively, mounting evidence indicates that inflammation, particularly via the NLRP3–caspase-1–GSDMD/IL-1β/IL-18 axis, is a central driver of both electrical and structural remodeling in AF. The gene discussed is IL18; the disease is atrial fibrillation.